We are live on
!
Find out more
BCC
Bridge City Capital Portfolio holdings
AUM
$361M
1-Year Est. Return
38.29%
This Fund
S&P 500
This Quarter
Est. Return
+5.39%
1 Year Est. Return
+38.29%
3 Year Est. Return
+76.88%
5 Year Est. Return
+81.43%
10 Year Est. Return
–
AUM
$293M
AUM Growth
-$8.37M
(-2.8%)
Cap. Flow
-$18.5M
Cap. Flow
% of AUM
-6.32%
Top 10 Holdings %
Top 10 Hldgs %
20.34%
Holding
97
New
2
Increased
6
Reduced
84
Closed
5
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CMBM
Cambium Networks
CMBM
|
+$1.71M |
| 2 |
IRBT
iRobot
IRBT
|
+$970K |
| 3 |
LHCG
LHC Group LLC
LHCG
|
+$690K |
| 4 |
INVX
Innovex International
INVX
|
+$647K |
| 5 |
Semtech
SMTC
|
+$644K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Haemonetics
HAE
|
+$5.33M |
| 2 |
EGOV
NIC Inc
EGOV
|
+$3.11M |
| 3 |
HMSY
HMS Holdings Corp.
HMSY
|
+$2.33M |
| 4 |
LMNX
Luminex Corp
LMNX
|
+$1.93M |
| 5 |
Green Dot
GDOT
|
+$1.75M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 27.73% |
| 2 | Technology | 21.34% |
| 3 | Consumer Discretionary | 18.35% |
| 4 | Industrials | 13.32% |
| 5 | Financials | 5.48% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
The Ensign Group
ENSG
$10B
| $7.8M | 2.66% |
90,004
-2,947
| -3% | -$255K |
|
2
Onto Innovation
ONTO
$13.8B
| $7.28M | 2.48% |
99,713
-3,223
| -3% | -$221K |
|
3
Methode Electronics
MEI
$564M
| $6.6M | 2.25% |
134,173
-4,605
| -3% | -$215K |
|
4
Emcor
EME
$33.6B
| $6M | 2.04% |
48,672
-1,631
| -3% | -$199K |
|
5
Coherent
COHR
$56.6B
| $5.74M | 1.96% |
79,043
-2,590
| -3% | -$182K |
|
6
AMN Healthcare
AMN
$1.28B
| $5.66M | 1.93% |
58,326
-1,926
| -3% | -$167K |
|
7
LeMaitre Vascular
LMAT
$2.19B
| $5.5M | 1.88% |
90,132
-3,003
| -3% | -$160K |
|
8
Lithia Motors
LAD
$7.79B
| $5.23M | 1.78% |
15,227
-505
| -3% | -$183K |
|
9
Omnicell
OMCL
$1.84B
| $4.97M | 1.69% |
32,809
-1,073
| -3% | -$149K |
|
|
10
Semtech
SMTC
$12.2B
| $4.87M | 1.66% |
70,809
+9,734
| +16% | +$644K |
|
|
PRFT
11
DELISTED
Perficient Inc
PRFT
| $4.74M | 1.62% |
58,969
-1,900
| -3% | -$134K |
|
12
Medpace
MEDP
$16.9B
| $4.56M | 1.56% |
25,829
-885
| -3% | -$153K |
|
13
WD-40
WDFC
$3.11B
| $4.55M | 1.55% |
17,752
-608
| -3% | -$155K |
|
14
TTEC Holdings
TTEC
$102M
| $4.51M | 1.54% |
43,737
-1,457
| -3% | -$151K |
|
15
US Physical Therapy
USPH
$1.14B
| $4.45M | 1.52% |
38,398
-1,350
| -3% | -$155K |
|
16
Ziff Davis
ZD
$1.93B
| $4.45M | 1.52% |
37,163
-1,321
| -3% | -$145K |
|
17
Neogen
NEOG
$2.05B
| $4.44M | 1.51% |
96,465
-3,229
| -3% | -$149K |
|
18
Globus Medical
GMED
$10.5B
| $4.41M | 1.5% |
56,878
-1,907
| -3% | -$136K |
|
19
Glacier Bancorp
GBCI
$6.55B
| $4.35M | 1.48% |
79,048
-2,610
| -3% | -$153K |
|
20
Diodes
DIOD
$4.06B
| $4.33M | 1.48% |
54,294
-1,888
| -3% | -$145K |
|
21
Healthcare Services Group
HCSG
$1.55B
| $4.3M | 1.47% |
136,334
-4,527
| -3% | -$138K |
|
|
AXON
22
Axon Enterprise
AXON
$40.2B
| $4.24M | 1.45% |
24,005
-795
| -3% | -$117K |
|
23
Supernus Pharmaceuticals
SUPN
$2.7B
| $4.24M | 1.45% |
137,782
-4,581
| -3% | -$140K |
|
24
RBC Bearings
RBC
$19.1B
| $4.21M | 1.44% |
21,130
-736
| -3% | -$145K |
|
|
LHCG
25
DELISTED
LHC Group LLC
LHCG
| $4.21M | 1.44% |
21,036
+3,440
| +20% | +$690K |
|
Similar funds
PPG
VWM
PWC
MCM
PI
SWM
RA
WIP
Bridge City Capital's Q2 2021 Portfolio in Review
As of Q2 2021, Bridge City Capital held 97 positions worth $293M, down 2.8% from $302M the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Bridge City Capital withdrew a net $18.5M in Q2 2021, closing 5 positions and reducing 84 holdings. Its most notable exit was Haemonetics, an estimated $5.33M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 28% of assets, down from 28% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, Bridge City Capital opened a new position in Cambium Networks worth $1.55M.
- Bridge City Capital's largest Q2 2021 buy was Cambium Networks: 32,025 shares worth $1.55M.
- Bridge City Capital added most to iRobot in Q2 2021, an estimated $970K increase.
- Bridge City Capital's biggest Q2 2021 reduction was MasTec, cutting an estimated $1M.
- Bridge City Capital fully exited Haemonetics in Q2 2021, selling an estimated $5.33M.
- Bridge City Capital's ten largest holdings make up 20% of its $293M portfolio in Q2 2021.
- Bridge City Capital opened 2 new positions and closed 5 in Q2 2021.
- Bridge City Capital's portfolio value fell 2.8% quarter-over-quarter to $293M.
Based on Bridge City Capital's 13F filing for Q2 2021, filed 11 Aug 2021.